Literature DB >> 25108041

Acute repeated intracerebroventricular injections of angiotensin II reduce agonist and antagonist radioligand binding in the paraventricular nucleus of the hypothalamus and median preoptic nucleus in the rat brain.

Robert C Speth1, Peter J Vento2, Eduardo J Carrera3, Luz Gonzalez-Reily4, Andrea Linares4, Kira Santos4, Jamala D Swindle4, Derek Daniels5.   

Abstract

Angiotensin II (Ang II) stimulates water and saline intakes when injected into the brain of rats. This arises from activation of the AT1 Ang II receptor subtype. Acute repeated injections, however, decrease the water intake response to Ang II without affecting saline intake. Previous studies provide evidence that Ang II-induced water intake is mediated via the classical G protein coupling pathway, whereas the saline intake caused by Ang II is mediated by an ERK 1/2 MAP kinase signaling pathway. Accordingly, the different behavioral response to repeated injections of Ang II may reflect a selective effect on G protein coupling. To test this hypothesis, we examined the binding of a radiolabeled agonist ((125)I-sarcosine(1) Ang II) and a radiolabeled antagonist ((125)I-sarcosine(1), isoleucine(8) Ang II) in brain homogenates and tissue sections prepared from rats given repeated injections of Ang II or vehicle. Although no treatment-related differences were found in hypothalamic homogenates, a focus on specific brain structures using receptor autoradiography, found that the desensitization treatment reduced binding of both radioligands in the paraventricular nucleus of the hypothalamus (PVN) and median preoptic nucleus (MnPO), but not in the subfornical organ (SFO). Because G protein coupling is reported to have a selective effect on agonist binding without affecting antagonist binding, these findings do not support a G protein uncoupling treatment effect. This suggests that receptor number is more critical to the water intake response than the saline intake response, or that pathways downstream from the G protein mediate desensitization of the water intake response.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AT(1) angiotensin receptors; Angiotensin; Brain; Desensitization; Hypertension; Radioligand; Saline intake; Thirst; Water intake

Mesh:

Substances:

Year:  2014        PMID: 25108041      PMCID: PMC4294181          DOI: 10.1016/j.brainres.2014.07.053

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  33 in total

1.  Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand.

Authors:  L Hein; L Meinel; R E Pratt; V J Dzau; B K Kobilka
Journal:  Mol Endocrinol       Date:  1997-08

2.  Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.

Authors:  R C Speth; K H Kim
Journal:  Biochem Biophys Res Commun       Date:  1990-06-29       Impact factor: 3.575

3.  Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes.

Authors:  H Kodama; K Fukuda; J Pan; S Makino; M Sano; T Takahashi; S Hori; S Ogawa
Journal:  Circ Res       Date:  1998-02-09       Impact factor: 17.367

4.  Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.

Authors:  Marie Mi Bonde; Jonas Tind Hansen; Samra Joke Sanni; Stig Haunsø; Steen Gammeltoft; Christina Lyngsø; Jakob Lerche Hansen
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

5.  Phosphorylation of the angiotensin II (AT1A) receptor carboxyl terminus: a role in receptor endocytosis.

Authors:  W G Thomas; T J Motel; C E Kule; V Karoor; K M Baker
Journal:  Mol Endocrinol       Date:  1998-10

6.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon.

Authors:  M Rodbell; H M Krans; S L Pohl; L Birnbaumer
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

7.  The hepatic angiotensin II receptor. II. Effect of guanine nucleotides and interaction with cyclic AMP production.

Authors:  J K Crane; C P Campanile; J C Garrison
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

8.  Tachyphylaxis of dipsogenic activity to intracerebroventricular administration of angiotensins.

Authors:  W S Quirk; J W Wright; J W Harding
Journal:  Brain Res       Date:  1988-06-14       Impact factor: 3.252

9.  Effect of uncoupling agents on AT1 receptor affinity for antagonist analogs of angiotensin II.

Authors:  M Poitras; A Sidibé; D E Richard; L Chrétien; G Guillemette
Journal:  Receptors Channels       Date:  1998

10.  FURO/CAP: a protocol for sodium intake sensitization.

Authors:  Daniela T B Pereira; José V Menani; Laurival A De Luca
Journal:  Physiol Behav       Date:  2009-12-24
View more
  5 in total

1.  Continuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse.

Authors:  Hirohisa Kawahata; Daisuke Sotobayashi; Motokuni Aoki; Hideo Shimizu; Hironori Nakagami; Toshio Ogihara; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

2.  Associative learning contributes to the increased water intake observed after daily injections of angiotensin II.

Authors:  Maggie Postolache; Jessica Santollo; Derek Daniels
Journal:  Physiol Behav       Date:  2017-07-04

3.  Properly timed exposure to central ANG II prevents behavioral sensitization and changes in angiotensin receptor expression.

Authors:  Jessica Santollo; Philip E Whalen; Robert C Speth; Stewart D Clark; Derek Daniels
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-10-29       Impact factor: 3.619

4.  Glutamatergic neurons of the paraventricular nucleus are critical contributors to the development of neurogenic hypertension.

Authors:  Tyler Basting; Jiaxi Xu; Snigdha Mukerjee; Joel Epling; Robert Fuchs; Srinivas Sriramula; Eric Lazartigues
Journal:  J Physiol       Date:  2018-09-20       Impact factor: 5.182

5.  Non-Invasive Strategies for Nose-to-Brain Drug Delivery.

Authors:  J T Trevino; R C Quispe; F Khan; V Novak
Journal:  J Clin Trials       Date:  2020-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.